On April 2, 2012, the Federal Trade Commission (FTC) closed its eight month investigation into the proposed merger of Express Scripts Inc. and Medco Health Solutions, approving the $29 billion deal with no strings attached. Through the PCPAN (Preserve Community Pharmacy Access Now) Coalition, IPA had signed on to oppose the PBM merger.  Among the continued concerns is that a merged ESI-Medco will reduce access and service to patients; reduce competition for PBM services (e.g., specialty products, mail order), and control a large share of the supply line for brand and generic prescription drugs.  To learn more, you may read the official press release of the FTC as well as NCPA’s press release and news from APhA.

From a claims processing perspective, continue your normal procedures as there will be no immediate changes in claims adjudication for either Express Scripts or Medco.  You may also utilize the attached Q&A to further address any questions or concerns you may have.